Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11166928rdf:typepubmed:Citationlld:pubmed
pubmed-article:11166928lifeskim:mentionsumls-concept:C0034715lld:lifeskim
pubmed-article:11166928lifeskim:mentionsumls-concept:C0028351lld:lifeskim
pubmed-article:11166928lifeskim:mentionsumls-concept:C0006549lld:lifeskim
pubmed-article:11166928lifeskim:mentionsumls-concept:C0028246lld:lifeskim
pubmed-article:11166928lifeskim:mentionsumls-concept:C0221912lld:lifeskim
pubmed-article:11166928lifeskim:mentionsumls-concept:C0312418lld:lifeskim
pubmed-article:11166928lifeskim:mentionsumls-concept:C0021376lld:lifeskim
pubmed-article:11166928lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:11166928lifeskim:mentionsumls-concept:C0036667lld:lifeskim
pubmed-article:11166928lifeskim:mentionsumls-concept:C1705241lld:lifeskim
pubmed-article:11166928lifeskim:mentionsumls-concept:C1705242lld:lifeskim
pubmed-article:11166928pubmed:issue1-2lld:pubmed
pubmed-article:11166928pubmed:dateCreated2001-2-22lld:pubmed
pubmed-article:11166928pubmed:abstractTextWe investigated whether there are any differences between the Lewis and Sprague-Dawley (SD) rats in chronic inflammation-induced norepinephrine (NE) sensitivity of nociceptors. Activities of C-fiber nociceptors innervating rat hairy hindpaw skin were recorded in an in vitro skin-nerve preparation. Sixty-five percent of C-fibers from inflamed Lewis rats were excited by NE (10 microM), against only 38% of C-fibers from inflamed SD rats. The average of the total impulses evoked in response to NE was also significantly higher in Lewis rats. The alpha2-adrenoceptor antagonist CH 38083 (10 microM) and yohimbine (10 microM) consistently blocked the NE-excitation of both strains. These results show that after chronic inflammation, C-fiber nociceptors of Lewis strain rats have a stronger sensitivity to NE, and that alpha2-adrenoceptors are predominately involved in the NE-sensitivity of inflamed rats in both strains.lld:pubmed
pubmed-article:11166928pubmed:languageenglld:pubmed
pubmed-article:11166928pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11166928pubmed:citationSubsetIMlld:pubmed
pubmed-article:11166928pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11166928pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11166928pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11166928pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11166928pubmed:statusMEDLINElld:pubmed
pubmed-article:11166928pubmed:monthFeblld:pubmed
pubmed-article:11166928pubmed:issn0304-3940lld:pubmed
pubmed-article:11166928pubmed:authorpubmed-author:YajimaHHlld:pubmed
pubmed-article:11166928pubmed:authorpubmed-author:SatoJJlld:pubmed
pubmed-article:11166928pubmed:authorpubmed-author:MizumuraKKlld:pubmed
pubmed-article:11166928pubmed:authorpubmed-author:BanikR KRKlld:pubmed
pubmed-article:11166928pubmed:issnTypePrintlld:pubmed
pubmed-article:11166928pubmed:day16lld:pubmed
pubmed-article:11166928pubmed:volume299lld:pubmed
pubmed-article:11166928pubmed:ownerNLMlld:pubmed
pubmed-article:11166928pubmed:authorsCompleteYlld:pubmed
pubmed-article:11166928pubmed:pagination21-4lld:pubmed
pubmed-article:11166928pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11166928pubmed:meshHeadingpubmed-meshheading:11166928...lld:pubmed
pubmed-article:11166928pubmed:meshHeadingpubmed-meshheading:11166928...lld:pubmed
pubmed-article:11166928pubmed:meshHeadingpubmed-meshheading:11166928...lld:pubmed
pubmed-article:11166928pubmed:meshHeadingpubmed-meshheading:11166928...lld:pubmed
pubmed-article:11166928pubmed:meshHeadingpubmed-meshheading:11166928...lld:pubmed
pubmed-article:11166928pubmed:meshHeadingpubmed-meshheading:11166928...lld:pubmed
pubmed-article:11166928pubmed:meshHeadingpubmed-meshheading:11166928...lld:pubmed
pubmed-article:11166928pubmed:meshHeadingpubmed-meshheading:11166928...lld:pubmed
pubmed-article:11166928pubmed:meshHeadingpubmed-meshheading:11166928...lld:pubmed
pubmed-article:11166928pubmed:meshHeadingpubmed-meshheading:11166928...lld:pubmed
pubmed-article:11166928pubmed:meshHeadingpubmed-meshheading:11166928...lld:pubmed
pubmed-article:11166928pubmed:meshHeadingpubmed-meshheading:11166928...lld:pubmed
pubmed-article:11166928pubmed:meshHeadingpubmed-meshheading:11166928...lld:pubmed
pubmed-article:11166928pubmed:meshHeadingpubmed-meshheading:11166928...lld:pubmed
pubmed-article:11166928pubmed:meshHeadingpubmed-meshheading:11166928...lld:pubmed
pubmed-article:11166928pubmed:meshHeadingpubmed-meshheading:11166928...lld:pubmed
pubmed-article:11166928pubmed:meshHeadingpubmed-meshheading:11166928...lld:pubmed
pubmed-article:11166928pubmed:meshHeadingpubmed-meshheading:11166928...lld:pubmed
pubmed-article:11166928pubmed:year2001lld:pubmed
pubmed-article:11166928pubmed:articleTitleDifferences between the Lewis and Sprague-Dawley rats in chronic inflammation induced norepinephrine sensitivity of cutaneous C-fiber nociceptors.lld:pubmed
pubmed-article:11166928pubmed:affiliationDepartment of Neural Regulation, Research Institute of Environmental Medicine, Nagoya University, Nagoya 464-8601, Japan.lld:pubmed
pubmed-article:11166928pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11166928pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11166928lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11166928lld:pubmed